4-(6-Methoxy-2H-chromen-3-yl)-2-methyl-5-oxo-5H-indeno[1,2-b]pyridine-3-carbonitrile

Catalog No. :
ACSWSA039
CAS No. :
866145-00-8
Molecular Formula :
C24H16N2O3
Molecular Weight :
380.40

IUPAC Name:4-(6-methoxy-2H-chromen-3-yl)-2-methyl-5-oxo-5H-indeno[1,2-b]pyridine-3-carbonitrile

4-(6-Methoxy-2H-chromen-3-yl)-2-methyl-5-oxo-5H-indeno[1,2-b]pyridine-3-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(6-Methoxy-2H-chromen-3-yl)-2-methyl-5-oxo-5H-indeno[1,2-b]pyridine-3-carbonitrile
IUPAC Name4-(6-methoxy-2H-chromen-3-yl)-2-methyl-5-oxo-5H-indeno[1,2-b]pyridine-3-carbonitrile
MDL No.MFCD03787251
Molecular FormulaC24H16N2O3
Molecular Weight380.40
SMILESN#CC1=C(C)N=C2C(C(C3=C2C=CC=C3)=O)=C1C(CO4)=CC5=C4C=CC(OC)=C5
InChI KeyXWQMTEBDEIQHFB-UHFFFAOYSA-N
Synonym5H-Indeno[1,2-b]pyridine-3-carbonitrile, 4-(6-methoxy-2H-1-benzopyran-3-yl)-2-methyl-5-oxo-
CAS No.866145-00-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACSWSA039 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSWSA039 route product structure diagram
    ACSWSA039866145-00-8
Inquiry

2. ACSWSA039 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSWSA039 route product structure diagram
    ACSWSA039866145-00-8
Inquiry

Comments (0)